K052536 is an FDA 510(k) clearance for the ALGICELL AG. Classified as Dressing, Wound, Drug (product code FRO).
Submitted by Derma Sciences Canada, Inc. (Toronto, Orntario, CA). The FDA issued a Cleared decision on September 13, 2006 after a review of 363 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.
View all Derma Sciences Canada, Inc. devices